Outcomes of intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 90 years or older

Mayo Clinic Proceedings

Volumn 84, Issue 4, 2009, Pages 334-338

  Mateen, Farrah J ^a   Nasser, Majeed ^b   Spencer, Byron R ^c   Freeman, William D ^d   Shuaib, Ashfaq ^b   Demaerschalk, Bart M ^e   Wijdicks, Eelco F M ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MAYO CLINIC   (United States)

^d MAYO CLINIC   (United States)

^e MAYO CLINIC HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

AGED; ALZHEIMER DISEASE; ARTICLE; BARTHEL INDEX; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL PROTOCOL; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIAGNOSTIC IMAGING; DIFFUSE LEWY BODY DISEASE; DIFFUSION WEIGHTED IMAGING; DISABILITY; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; FATALITY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MALE; MILD COGNITIVE IMPAIRMENT; OUTCOME ASSESSMENT; RANKIN SCALE; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE; AGE; BRAIN ISCHEMIA; INTRAVENOUS DRUG ADMINISTRATION; MORTALITY; STROKE;

ACTIVITIES OF DAILY LIVING; AGE FACTORS; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; RETROSPECTIVE STUDIES; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 64749092071     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/84.4.334     Document Type: Article

References (25)

1. Hobbs FB. The elderly population. US Census Bureau Population Profile of the United States Web site. http://www.census.gov/population/www/popprofile/ elderpop.html. Accessed January 27, 2009.
2. Takamura JC. US Department of Health and Human Services. Testimony on "The Graying of Nations." Senate Special Committee on Aging Web site. June 8, 1998. http://www.hhs.gov/asl/testify/t980608b.html. Accessed January 27, 2009.
3. International Year of Older Persons: Demographics of Older Persons. United Nations Department of Public Information Web site. September 1999. http://www.un.org/NewLinks/older/99/older.htm. Accessed January 27, 2009.
4. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581-1587.
5. Hacke W, Kaste M, Fieschi C, et al; ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274(13):1017-1025.
6. Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS study: a randomized controlled trial. JAMA. 1999;282(21):2019-2026.
7. Clark WM, Albers GW, Madden KP, Hamilton S; Thrombolytic Therapy in Acute Ischemic Stroke Study Investigators. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Stroke. 2000;31(4):811-816.
8. Hacke W, Kaste M, Fieschi C, et al; Second European-Australasian Acute Stroke Study Investigators. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998;352(9136):1245-1251.
9. Hacke W, Kaste M, Bluhmki E, et al; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-1329.
10. Wardlaw JM, Zoppo G, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2003;3:CD000213.
11. Tanne D, Gorman MJ, Bates VE, et al. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: the tPA stroke survey experience. Stroke. 2000;31(2):370-375.
12. Zeevi N, Chhabra J, Silverman IE, Lee NS, McCullough LD. Acute stroke management in the elderly. Cerebrovasc Dis. 2007;23(4):304-308. Epub 2006 Dec 29.
13. Sharma JC, Fletcher S, Vassallo M. Strokes in the elderly-higher acute and 3-month mortality - an explanation. Cerebrovasc Dis. 1999;9(1):2-9.
14. van Oostenbrugge RJ, Hupperts RM, Lodder J. Thrombolysis for acute stroke with special emphasis on the very old: experience from a single Dutch centre. J Neurol Neurosurg Psychiatry. 2006;77(3):375-377.
15. Kammersgaard LP, Jørgensen HS, Reith J, Nakayama H, Pedersen PM, Olsen TS. Short- and long-term prognosis for very old stroke patients: Copenhagen stroke study. Age Ageing. 2004;33(2):149-154.
16. Di Carlo A, Lamassa M, Pracucci G, et al; European BIOMED Study of Stroke Care Group. Stroke in the very old: clinical presentation and determinants of 3-month functional outcome: a European perspective. Stroke. 1999;30(11):2313- 2319.
17. Heuschmann PU, Kolominsky-Rabas PL, Roether J, Misselwitz B, Lowitzsch K; German Stroke Registers Study Group. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. JAMA. 2004;292(15):1831-1838.
18. Simon JE, Sandler DL, Warwick Pexman JH, Hill MD, Buchan AM; Calgary Stroke Programme. Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - the Calgary experience. Age Ageing. 2004;33(2):143-149.
19. Berrouschot J, Röther J, Glahn J, Kucinski T, Fiehler J, Thomalla G. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (≥80 years) stroke patients. Stroke. 2005 Nov;36(11):2421-2425. Epub 2005 Oct 6.
20. Mouradian MS, Senthilselvan A, Jickling G, et al. Intravenous rt-PA for acute stroke: comparing its effectiveness in younger and older patients. J Neurol Neurosurg Psychiatry. 2005;76(9):1234-1237.
21. Chen CI, Iguchi Y, Grotta JC, et al. Intravenous TPA for very old stroke patients. Eur Neurol. 2005;54(3):140-144. Epub 2005 Oct 18.
22. Engelter ST, Bonati LH, Lyrer PA. Intravenous thrombolysis in stroke patients of ≥80 versus <80 years of age - a systematic review across cohort studies. Age Ageing. 2006;35(6):572-580.
23. Sylaja PN, Cote R, Buchan AM, Hills MD; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study. J Neurol Neurosurg Psychiatry. 2006 Jul;77(7):826-829. Epub 2006 Feb 27.
24. Engelter ST, Reichhart M, Sekoranja L, et al. Thrombolysis in stroke patients 80 years and older: Swiss survey of IV thrombolysis. Neurology. 2005 Dec 13;65(11):1795-1798. Epub 2005 Oct 12.
25. NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA Stroke Trial. Stroke. 1997;28(11):2119-2125.